Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 DiabetesRena R. Wing, Anne L. Peters, J. Bruce Redmon et al.|Diabetes Care|2007Cited by 1.5k
Adiponectin and development of type 2 diabetes in the Pima Indian populationRobert S. Lindsay, Jonathan Krakoff, Tohru Funahashi et al.|The Lancet|2002Cited by 1.1k
Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trialRena R. Wing, Edward W. Gregg, John M. Jakicic et al.|The Lancet Diabetes & Endocrinology|2016Cited by 728
Vitamin D Supplementation and Prevention of Type 2 DiabetesAnastassios G. Pittas, Myrlene A. Staten, Bess Dawson‐Hughes et al.|New England Journal of Medicine|2019Cited by 662
MYH9 is associated with nondiabetic end-stage renal disease in African AmericansW.H. Linda Kao, Rulan S. Parekh, Michael J. Klag et al.|Nature Genetics|2008Cited by 648